Latest Morning Briefing Stories
Media outlets report on news from Maryland, Minnesota, New York, Louisiana, Georgia, Ohio, Arkansas, Illinois, New Mexico, Michigan, Iowa, Missouri, Florida, Wisconsin, and Florida.
Researchers were excited about the possibilities, especially from one of the drugs that was able to reach tumors in the brain. Other pharmaceutical news focuses on insulin prices and biotech startups.
Email accounts involving phishing scams seem to be the primary target through which data is exposed. In other news on health technology, Google Health hires a leading researcher on wearables.
After months of delays, the House Energy And Commerce Committee released legislation that would tackle the issue of surprise medical bills. It has garnered bipartisan support in Congress and won backing from President Donald Trump. But Ways and Means Committee lawmakers think their proposal is better.
In the sixth week of open enrollment for 2019 coverage, there had been a 12% drop off. For 2020 coverage the sign-ups are lagging by 6%. These numbers don’t include people who will be automatically enrolled in their coverage, and there also is usually a flurry in the last few days before the Dec. 15 deadline.
But the flip side is that families may be unprepared to handle a seriously sick relative.
The House Judiciary Committee is unique in that it seems almost designed for fiery disagreements between lawmakers who are firmly on their own side of the aisle on all issues. It’s also played host to many abortion battles over the decades.
Vivitrol, manufactured by Alkermes, is meant to help those recovering for addiction, but it also lowers tolerance to opioids. That means if patients relapse while taking it they are far more vulnerable to overdoses.
Several children died in U.S. custody because of the flu and the CDC recommended that migrants are given the vaccine. But officials say that trying to provide flu shots to everyone during the few days they spend in Border Patrol custody does not make sense. A group of doctors launched a protest in response to the refusal that spanned the past three days.
House Speaker Nancy Pelosi’s drug plan includes many policies that President Donald Trump himself has touted. It was almost a dare for him to fight against it, and at first he seemed interested. That all changed with impeachment.
The conflict between HHS Secretary Alex Azar and CMS Administrator Seema Verma has become increasingly public and messy. As voters have been vocal about the importance of health care in recent elections, could the infighting be a distraction that President Donald Trump doesn’t need heading into a tough 2020?
Media outlets report on news from the District of Columbia, Florida, Texas, Pennsylvania, North Carolina, Maryland, Louisiana, Ohio, Georgia, Louisiana, Oregon, Minnesota, Missouri and California.
The report comes amid the state’s struggle to contain costs for its Medicaid program. Medicaid news comes out of Kentucky, Maine and Wisconsin, as well.
Cigna has been working to trim debt after last year’s acquisition of pharmacy-benefits manager Express Scripts Holding Co. for $54 billion. In other news from the health industry: a corporation misses the deadline to close the deal on four Verity Health hospitals and a look at the small Medicare reduction that could make a big difference in premiums.
The letter prompted the recipients to sign up for health coverage to avoid penalties, which in turn prevented premature deaths that would have occurred without it. It was essentially the first rigorous experiment to find that health coverage leads to fewer deaths, a claim that politicians and economists have fiercely debated in recent years
It’s likely that Democrats are viewing House Speaker Nancy Pelosi’s drug pricing bill as a political tool rather than a realistic goal. The legislation is already being used in ads for vulnerable Democrats and candidates are planning to tout it as a main component of their health care agendas. “Republicans will spend the next year defending their decision to block Medicare from lowering prescription drug prices for everyone,” said Jesse Ferguson, a veteran Democratic messaging consultant. After Pelosi secured a deal with the progressive wing of her party, the House is set to vote on the bill on Thursday.
Democrats argue that enshrining a 10-year guarantee in the United States-Mexico-Canada Agreement would have tied Congress’ hands if lawmakers wanted to change the threshold. “This deal would have caused prices of prescription drugs in those countries to skyrocket,” said Rep. Jan Schakowsky (D-Ill.). Pharmaceutical lobbyists were harsh in their assessment: “This was an unforced error and very, very weak negotiating.”
Acting White House chief of staff Mick Mulvaney has now summoned HHS Secretary Alex Azar and CMS Administrator Seema Verma to meet at the White House this week to see if they can continue to work together amid the bickering. Meanwhile, allegations continue to emerge about who is leaking what information and the motives behind the riff.
South Bend Mayor Pete Buttigieg drew fire on the presidential campaign trail for his consulting work for McKinsey. Buttigieg says he “never worked on a project” inconsistent with his values, and maintains that although he worked with Blue Cross Blue Shield of Michigan during his tenure, he focused on expenditures like rent, utilities and company travel. Two years after he worked on the case, the insurer cut up to 1,000 jobs.
The government promised to cushion the blow for some insurers if they entered the health law marketplace, but then Congress stripped the money out of the budget. The insurers say they are owed $12 billion. From the questions during the oral arguments it seems like the Supreme Court justices may agree, though both Chief Justice John Roberts and Justice Samuel Alito were skeptical of some of the insurers’ points.